EUCTR2011-003433-33-Outside-EU/EEA进行中（未招募）不适用
A Single Dose Biocomparison Study to Assess two Pediatric Formulations of MK-8669 to the Provisional Market Formulation in Healthy Subjects - A Single Dose Study to Assess the Biocomparison of MK-8669 in Subjects
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Healthy, male subjects, aged 18 to 45 years.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 21
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subject has a history of any illness that, in the opinion of the study investigator, might confound the results of the study or poses an additional risk to the subject by their participation in the study.
研究者
相似试验
已完成
1 期
A Bioequivalence study of single dose, two-way crossover design with two-period, two-treatment of Octreotide-SBS 100 mcg/mL subcutaneous injection relative to Sandostatin®Healthy VolunteersTCTR20180920004Siam Bioscience28
已完成
1 期
Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, FedHypertension, EssentialNCT01350609Bayer49
已完成
不适用
bioequivalence of febuxostatIRCT20200705048005N1ChemiDaru Pharmaceutical Company26
已完成
1 期
Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting ConditionsHypertension, EssentialNCT01227603Bayer49
已完成
不适用
A Single dose, two-way crossover study of the bioequivalence of two formulations of Ribaviri10019654Hepatitis CNL-OMON36756Schering-Plough54